Abstract Details

Title Clinical Utility of [sup]18[/sup]F fluoro-2-deoxyglucose (FDG) PET Scanning in Undiagnosed Progressive Neurological Syndromes

Topic

Presentation(s)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Supriya Mahajan, MD (Neurology Center, Inc)	Dr. Mahajan has nothing to disclose.
Ken Ikeda, MD, PhD (Toho University Omori Medical Center)	No disclosure on file
Osamu Kano, MD, PhD (Department of Neurology, Toho University Faculty of Medicine)	Dr. Kano has nothing to disclose.
Kiyokazu Kawabe, MD (Department of Neurology Saiseikai Yokohamashi Tobu Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Yasuo Iwasaki, MD	No disclosure on file

��ɫ��